ONCY

Oncolytics Biotech
ONCY

55 hedge funds and large institutions have $1.15M invested in Oncolytics Biotech in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0% more ownership

Funds ownership: 1.58% → 1.58% (+0%)

Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$26.1K
2
+$16.3K
3
+$15.5K
4
HL
HeadInvest LLC
Maine
+$15.5K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
+$15K

Top Sellers

1
-$11K
2
-$8.88K
3
-$8.34K
4
GSC
Ground Swell Capital
South Carolina
-$7.97K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$6.61K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIS
51
Sound Income Strategies
Florida
$150
IA
52
IFP Advisors
Florida
$77
AF
53
Aviso Financial
Ontario, Canada
$39
WWM
54
Wolff Wiese Magana
California
$32
Russell Investments Group
55
Russell Investments Group
United Kingdom
$1
Susquehanna International Group
56
Susquehanna International Group
Pennsylvania
–
LPL Financial
57
LPL Financial
California
–
TSS
58
Two Sigma Securities
New York
–
GSC
59
Ground Swell Capital
South Carolina
–
TRCT
60
Tower Research Capital (TRC)
New York
–
SPIA
61
Steward Partners Investment Advisory
New York
–
1 2
3